A way forward on the medically appropriate use of white cell growth factors

J Clin Oncol. 2012 May 10;30(14):1584-7. doi: 10.1200/JCO.2011.39.9980. Epub 2012 Feb 27.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cost-Benefit Analysis
  • Disease-Free Survival
  • Evidence-Based Medicine
  • Female
  • Follow-Up Studies
  • Forecasting
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / economics
  • Hematopoietic Stem Cell Transplantation / trends*
  • Humans
  • Male
  • Maximum Tolerated Dose
  • Neoplasms / mortality*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Patient Selection
  • Practice Guidelines as Topic
  • Receptors, Colony-Stimulating Factor / administration & dosage*
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Analysis
  • Treatment Outcome

Substances

  • Receptors, Colony-Stimulating Factor